Novel strategies in the treatment of relapsed/refractory multiple myeloma. From the Multiple Myeloma Research Foundation.
Richardson
Paul
P
Department of Medical Oncology/Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
D000328:Adult; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D009101:Multiple Myeloma / Q000188:drug therapy*; D012008:Recurrence
D000970:Antineoplastic Agents